Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy
Cell Reports Medicine
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy. // Cell Reports Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S2666379126005446?dgcid=rss_sd_all
Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy. Cell Reports Medicine. https://www.sciencedirect.com/science/article/pii/S2666379126005446?dgcid=rss_sd_all
“Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy.” Cell Reports Medicine.
@article{article88739,
title = {Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy},
journal = {Cell Reports Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S2666379126005446?dgcid=rss_sd_all}
}